- My News
- All News
- Most Popular
According to a CDSCO official, 14 private companies, including Roche Diagnostics India, CoSara Diagnostics and CPC Diagnostics, have been given license by the Drug Controller General of India (DCGI) to evaluate the quality of COVID-19 testing kits and submit their data to the Drug Controller General of India, as reported The Economic Times on Friday.
Roche Diagnostics India received the license from the DCGI for its cobas SARS CoV-2 diagnostic test kit on March 17.
"We are now assessing giving license to another private diagnostic firm, bioMerieux, which has also sought approval besides three other companies," said an official from Central Drugs Standard Control Organisation.
The development comes after the Indian Council of Medical Research announced that accredited private labs will conduct tests for COVID-19 to enhance capacity for diagnosis amid rising cases in the country.
Did you like this article?